clinical trial · NCT00650325
Study of Sertraline Hydrochloride Tablets 100 mg and Zoloft® Tablets 100 mg
HealthySertraline Hydrochloride Tablets 100 mgZoloft® Tablets 100 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's sertraline hydrochloride 100 mg tablets to Pfizer's Zoloft® 100 mg tablets following a single, oral 100 mg (1 x 100 mg) dose administered under fasting conditions.
started
Nov 1, 2002
primary completion
Dec 1, 2002
completion
Dec 1, 2002
last updated
Apr 24, 2024
official title
Single-Dose Fasting In Vivo Bioequivalence Study of Sertraline Hydrochloride Tablets (100 mg; Mylan) and Zoloft® Tablets (100 mg; Pfizer) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol